Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Diagnosed Multiple Myeloma (MM) Transplant Ineligible Patients

Clinical trial NCT03001804 · COMPLETED

Trial details

NCT number: NCT03001804
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2017-06-30
Primary completion: 2022-12-16
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.